Neuropilin-1 expressing melanoma cells as a model to study the aggressiveness of metastatic melanoma

por Ruffini, Federica, Graziani, Grazia, Levati, Lauretta, Tentori, Lucio, Caporali, Simona, D’Atri, Stefania, Lacal, Pedro M
Publicado 2015

Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1

por Ruffini, Federica, Levati, Lauretta, Graziani, Grazia, Caporali, Simona, Atzori, Maria Grazia, D’Atri, Stefania, Lacal, Pedro M.
Publicado 2017

hTERT Transduction Extends the Lifespan of Primary Pediatric Low-Grade Glioma Cells While Preserving the Biological Response to NGF

por Franzese, Ornella, Di Francesco, Angela M., Meco, Daniela, Graziani, Grazia, Cusano, Gabriella, Levati, Lauretta, Riccardi, Riccardo, Ruggiero, Antonio
Publicado 2021

NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug

por Caporali, Simona, Levati, Lauretta, Graziani, Grazia, Muzi, Alessia, Atzori, Maria Grazia, Bonmassar, Enzo, Palmieri, Giuseppe, Ascierto, Paolo A, D’Atri, Stefania
Publicado 2012

Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib

por Caporali, Simona, Alvino, Ester, Lacal, Pedro Miguel, Ruffini, Federica, Levati, Lauretta, Bonmassar, Laura, Scoppola, Alessandro, Marchetti, Paolo, Mastroeni, Simona, Antonini Cappellini, Gian Carlo, D’Atri, Stefania
Publicado 2017

Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals

por Tabolacci, Claudio, Cordella, Martina, Mariotti, Sabrina, Rossi, Stefania, Senatore, Cinzia, Lintas, Carla, Levati, Lauretta, D’Arcangelo, Daniela, Facchiano, Antonio, D’Atri, Stefania, Nisini, Roberto, Facchiano, Francesco
Publicado 2021

Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by i...

por Caporali, Simona, Alvino, Ester, Amaro, Adriana, Lacal, Pedro Miguel, Levati, Lauretta, Atzori, Maria Grazia, Cappellini, Gian Carlo Antonini, Ruffini, Federica, Bonmassar, Enzo, Pfeffer, Ulrich, D’Atri, Stefania
Publicado 2015

miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A

por Caporali, Simona, Amaro, Adriana, Levati, Lauretta, Alvino, Ester, Lacal, Pedro Miguel, Mastroeni, Simona, Ruffini, Federica, Bonmassar, Laura, Antonini Cappellini, Gian Carlo, Felli, Nadia, Carè, Alessandra, Pfeffer, Ulrich, D’Atri, Stefania
Publicado 2019

Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients

por Carbone, Maria Luigia, Madonna, Gabriele, Capone, Alessia, Bove, Marianna, Mastroeni, Simona, Levati, Lauretta, Capone, Mariaelena, Ascierto, Paolo Antonio, De Galitiis, Federica, D’Atri, Stefania, Fortes, Cristina, Volpe, Elisabetta, Failla, Cristina Maria
Publicado 2022

A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose

por Sbardella, Diego, Tundo, Grazia Raffaella, Mecchia, Alice, Palumbo, Camilla, Atzori, Maria Grazia, Levati, Lauretta, Boccaccini, Alessandra, Caccuri, Anna Maria, Cascio, Paolo, Lacal, Pedro Miguel, Graziani, Grazia, Varano, Monica, Coletta, Massimiliano, Parravano, Mariacristina
Publicado 2022

Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy

por Levati, Lauretta, Bassi, Cristian, Mastroeni, Simona, Lupini, Laura, Antonini Cappellini, Gian Carlo, Bonmassar, Laura, Alvino, Ester, Caporali, Simona, Lacal, Pedro Miguel, Narducci, Maria Grazia, Molineris, Ivan, De Galitiis, Federica, Negrini, Massimo, Russo, Giandomenico, D’Atri, Stefania
Publicado 2022